Michael D. Carter

1.2k total citations
42 papers, 766 citations indexed

About

Michael D. Carter is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Michael D. Carter has authored 42 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Michael D. Carter's work include Polyomavirus and related diseases (6 papers), Cancer Genomics and Diagnostics (5 papers) and Antenna Design and Analysis (5 papers). Michael D. Carter is often cited by papers focused on Polyomavirus and related diseases (6 papers), Cancer Genomics and Diagnostics (5 papers) and Antenna Design and Analysis (5 papers). Michael D. Carter collaborates with scholars based in Canada, United States and New Zealand. Michael D. Carter's co-authors include H. Anthony Pattinson, David M. Cox, Renée H. Martin, Alfred Rademaker, Noreen M. Walsh, Sylvia Pasternak, Thai Yen Ly, David Owen, Martin G. McLoughlin and Steve Doucette and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Journal of Medicinal Chemistry.

In The Last Decade

Michael D. Carter

39 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael D. Carter Canada 13 209 200 150 145 106 42 766
C Satoh Japan 19 523 2.5× 134 0.7× 306 2.0× 16 0.1× 54 0.5× 32 1.1k
D. Warburton United States 21 846 4.0× 80 0.4× 566 3.8× 47 0.3× 145 1.4× 42 1.6k
Catherine Quigley United States 10 435 2.1× 170 0.8× 225 1.5× 138 1.0× 165 1.6× 16 850
Masahiko Harata Japan 29 1.7k 8.0× 126 0.6× 218 1.5× 26 0.2× 43 0.4× 77 2.0k
Rosemary Ekong United Kingdom 19 693 3.3× 163 0.8× 544 3.6× 21 0.1× 168 1.6× 34 1.5k
Alec R. Chapman United States 7 1.3k 6.3× 200 1.0× 379 2.5× 24 0.2× 77 0.7× 8 1.9k
Brian Reichholf Austria 8 961 4.6× 50 0.3× 72 0.5× 92 0.6× 65 0.6× 9 1.1k
Veronika A. Herzog Austria 11 1.2k 5.9× 51 0.3× 87 0.6× 94 0.6× 71 0.7× 17 1.4k
Viatcheslav R. Akmaev United States 14 944 4.5× 49 0.2× 167 1.1× 17 0.1× 36 0.3× 37 1.6k
L.E. McGann Canada 15 224 1.1× 51 0.3× 40 0.3× 203 1.4× 283 2.7× 32 792

Countries citing papers authored by Michael D. Carter

Since Specialization
Citations

This map shows the geographic impact of Michael D. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Carter more than expected).

Fields of papers citing papers by Michael D. Carter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Carter. The network helps show where Michael D. Carter may publish in the future.

Co-authorship network of co-authors of Michael D. Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Carter. A scholar is included among the top collaborators of Michael D. Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Carter. Michael D. Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carter, Michael D., Shaan Dudani, Jonathan M. Loree, et al.. (2024). Novel Approach to Proficiency Testing Highlights Key Practice Variations in Cancer Biomarker Delivery. SHILAP Revista de lepidopterología. 5(1). 1–10. 4 indexed citations
2.
Snow, Stephanie, Christine Brezden‐Masley, Michael D. Carter, et al.. (2024). Barriers and Unequal Access to Timely Molecular Testing Results: Addressing the Inequities in Cancer Care Delays across Canada. Current Oncology. 31(3). 1359–1375. 12 indexed citations
3.
4.
Husereau, Don, Yvonne Bombard, Tracy Stockley, et al.. (2023). Future Role of Health Technology Assessment for Genomic Medicine in Oncology: A Canadian Laboratory Perspective. Current Oncology. 30(11). 9660–9669. 3 indexed citations
5.
Park, Paul C., Kyle C. Kurek, John F. DeCoteau, et al.. (2022). CAP-ACP Workload Model for Advanced Diagnostics in Precision Medicine. American Journal of Clinical Pathology. 158(1). 105–111. 2 indexed citations
6.
Walsh, Noreen M., Daniel Gaston, Thai Yen Ly, et al.. (2022). RB1-deficient squamous cell carcinoma: the proposed source of combined Merkel cell carcinoma. Modern Pathology. 35(12). 1829–1836. 13 indexed citations
7.
Carter, Michael D., Sylvia Pasternak, Daniel Gaston, et al.. (2021). Relationship between p63 and p53 expression in Merkel cell carcinoma and corresponding abnormalities in TP63 and TP53: a study and a proposal. Human Pathology. 117. 31–41. 7 indexed citations
8.
Al‐Omari, Ahmed, Michael D. Carter, Paul W. Harms, et al.. (2020). DNA copy number changes correlate with clinical behavior in melanocytic neoplasms: proposal of an algorithmic approach. Modern Pathology. 33(7). 1307–1317. 21 indexed citations
9.
Walsh, Noreen M., Andrea Saggini, Sylvia Pasternak, et al.. (2020). p63 expression in Merkel cell carcinoma: comparative immunohistochemistry invokes TAp63 as the dominant isoform involved. Human Pathology. 97. 60–67. 10 indexed citations
10.
Gupta, Mayuri, et al.. (2019). Inhibition of Pantothenate Synthetase by Analogs of β-Alanine Precursor Ineffective as an Antibacterial Strategy. Chemotherapy. 64(1). 22–27. 4 indexed citations
11.
Carter, Michael D., et al.. (2019). EWSR1‐PBX3 gene fusion in cutaneous syncytial myoepithelioma. Journal of Cutaneous Pathology. 46(6). 421–424. 9 indexed citations
12.
Carter, Michael D., Alison B. Durham, Paul W. Harms, et al.. (2018). Molecular testing of borderline cutaneous melanocytic lesions: SNP array is more sensitive and specific than FISH. Human Pathology. 86. 115–123. 16 indexed citations
13.
Meyers, Joshua, N. Chessum, N. Yi Mok, et al.. (2018). Privileged Structures and Polypharmacology within and between Protein Families. ACS Medicinal Chemistry Letters. 9(12). 1199–1204. 12 indexed citations
14.
Carter, Michael D., et al.. (2017). Percutaneous sharp recanalization of a membranous IVC occlusion with an occlusion balloon as a needle target. Radiology Case Reports. 12(3). 537–541. 2 indexed citations
15.
Carter, Michael D., Daniel Gaston, Weei‐Yuarn Huang, et al.. (2017). Genetic profiles of different subsets of Merkel cell carcinoma show links between combined and pure MCPyV-negative tumors. Human Pathology. 71. 117–125. 53 indexed citations
16.
Carter, Michael D., et al.. (2015). A rare case of bladder chondroma. Canadian Urological Association Journal. 9(3-4). 136–136. 5 indexed citations
17.
Lukov, Georgi L., et al.. (2006). Mechanism of Assembly of G Protein βγ Subunits by Protein Kinase CK2-phosphorylated Phosducin-like Protein and the Cytosolic Chaperonin Complex. Journal of Biological Chemistry. 281(31). 22261–22274. 66 indexed citations
18.
Pattinson, H. Anthony, et al.. (1995). Chromosomal analysis of sperm from men with idiopathic infertility using sperm karyotyping and fluorescence in situ hybridization. Fertility and Sterility. 64(4). 811–817. 199 indexed citations
19.
Carter, Michael D.. (1995). An expository note on the composite commodity theorem. Economic Theory. 5(1). 175–179. 2 indexed citations
20.
Carter, Michael D., et al.. (1992). Collecting Duct Carcinoma of the Kidney: A Case Report and Review of the Literature. The Journal of Urology. 147(4). 1096–1098. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026